Annual General Meeting Results
On August 4, 2020, Affimed N.V. (“Affimed” or the “Company”) held its Annual General Meeting of Shareholders. The final results of
each of the agenda items submitted to a vote of the shareholders are as follows:
Agenda item 3: Adoption of the Statutory Annual Accounts for the
financial year 2019
Affimed shareholders approved the adoption of the statutory annual accounts for the financial year 2019.
Agenda item 4: Discharge of the managing directors for their management during the financial year 2019
Affimed shareholders approved the discharge of the managing directors for their management during the financial year 2019.
Agenda item 5: Discharge of the supervisory directors for their supervision during the financial year 2019
Affimed shareholders approved the discharge of the supervisory directors for their supervision during the financial year 2019.
Agenda item 6: Amendment of the Remuneration Policy for the Management Board
Affimed shareholders approved the amendment of the remuneration policy of the management board.
Agenda item 7: Amendment of the Remuneration Policy for the Supervisory Board
Affimed shareholders approved the amendment of the remuneration policy of the supervisory board.
Agenda item 8 a.: Reappointment of Dr. Adi Hoess as a managing director
Affimed shareholders approved the reappointment of Dr. Adi Hoess as a managing director.
Agenda item 8 b.: Reappointment of Dr. Wolfgang Fischer as a managing director
Affimed shareholders approved the reappointment of Dr. Wolfgang Fischer as a managing director.
Agenda item 8 c.: Appointment of Mr. Angus Smith as a managing director
Affimed shareholders approved the appointment of Mr. Angus Smith as a managing director.
Agenda item 8 d.: Appointment of Dr. Arndt Schottelius as a managing director
Affimed shareholders approved the appointment of Dr. Arndt Schottelius as a managing director.
Agenda item 8 e.: Appointment of Dr. Andreas Harstrick as a managing director
Affimed shareholders approved the appointment of Dr. Andreas Harstrick as a managing director.
Agenda item 9 a.: Reappointment of Dr. Thomas Hecht as a supervisory director
Affimed shareholders approved the reappointment of Dr. Thomas Hecht as a supervisory director.
Agenda item 9 b.: Reappointment of Mr. Ferdinand Verdonck as a supervisory director
Affimed shareholders approved the reappointment of Mr. Ferdinand Verdonck as a supervisory director.
Agenda item 9 c.: Appointment of Mr. Harry Welten as a supervisory director
Affimed shareholders approved the appointment of Mr. Harry Welten as a supervisory director.
Agenda item 9 d.: Appointment of Dr. Annalisa Jenkins as a supervisory director
Affimed shareholders approved the appointment of Dr. Annalisa Jenkins as a supervisory director.
Agenda item 10: Appointment of the auditor for the financial year 2020
Affimed shareholders approved the appointment of the auditor for the financial year 2020.
Agenda item 11: Abolishment of the cumulative preference shares and amendment of the articles of association
Affimed shareholders approved the abolishment of the cumulative preference shares and amendment of the articles of association.
Agenda item 12: Authorization to acquire shares
Affimed shareholders approved the authorization to acquire shares.